Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics

Novo holdings panel asks diagnostics industry leaders how to keep the focus on testing post-pandemic

Executive Summary

How can stakeholders capitalize on this moment of acute public awareness of diagnostics to improve adoption of tests and screening in the long term? At a recent roundtable event, the CEOs of Roche Diagnostics, GE Healthcare, Labcorp and Synlab, among others, gave their thoughts on how the system must change.

You may also be interested in...



Roche Diagnostics Names Diagnostics Leader Schinecker As New CEO

The Swiss company is preparing for a smooth transition in 2023, appointing 20-year Roche veteran and diagnostic chief Thomas Schinecker as its next chief executive as Severin Schwan becomes chairman.

Swiss Parliament’s Vote For Medtech Innovation Succeeds

Another key stage has been reached in Switzerland’s bid to enable US FDA-approved medtech to be used in the local population.

German Digital Health Strategy And EPR Project Get A Reboot

Digitization of the German health care system has been slow to get going, as the health ministry readily admits. A fresh start should bring different results, the ministry’s head of e-health Sebastian Zilch told Medica attendees.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT144646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel